MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.410
-0.010
-0.70%
After Hours: 1.440 +0.03 +2.13% 17:34 02/11 EST
OPEN
1.410
PREV CLOSE
1.420
HIGH
1.450
LOW
1.360
VOLUME
3.05M
TURNOVER
--
52 WEEK HIGH
1.960
52 WEEK LOW
0.5150
MARKET CAP
461.52M
P/E (TTM)
-6.5037
1D
5D
1M
3M
1Y
5Y
1D
Top small-cap healthcare stocks surging above 200-day moving average
Seeking Alpha · 4h ago
Ocugen Announces New CFO Compensation Package with Severance and Equity Acceleration Terms
Reuters · 2d ago
Ocugen setzt neue Vergütungsregelungen für CFO Rita Johnson-Greene fest
Reuters · 2d ago
Ocugen taps Rita Johnson-Greene as CFO
Seeking Alpha · 2d ago
*Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer >OCGN
Dow Jones · 2d ago
Ocugen ernennt Rita Johnson-Greene zur Finanzchefin
Reuters · 2d ago
Ocugen Names Rita Johnson-Greene as Chief Financial Officer
Reuters · 2d ago
OCUGEN APPOINTS RITA JOHNSON-GREENE TO CHIEF FINANCIAL OFFICER
Reuters · 2d ago
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.